Shin Nishio

Summary

Affiliation: Kurume University School of Medicine
Country: Japan

Publications

  1. doi request reprint Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahi Machi, Kurume, Fukuoka, 830 0011, Japan
    Cancer Chemother Pharmacol 78:785-90. 2016
  2. doi request reprint Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Asahi machi 67, Kurume, Fukuoka, Japan Electronic address
    Gynecol Oncol 132:703-8. 2014
  3. doi request reprint Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia
    Shin Nishio
    Department of Basic Pathology, National Defense Medical College, 3 2 Namiki, Tokorozawa, Saitama 359 8513, Japan
    Pathol Res Pract 205:331-7. 2009
  4. doi request reprint Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    J Cancer Res Clin Oncol 135:551-7. 2009
  5. doi request reprint Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Cancer Lett 264:36-43. 2008
  6. ncbi request reprint [A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital
    Gan To Kagaku Ryoho 33:1589-93. 2006
  7. ncbi request reprint Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma
    Shin Nishio
    Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
    Oncol Rep 19:497-503. 2008
  8. ncbi request reprint Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka Pretecture, 830 0011, Japan
    Gynecol Oncol 106:342-7. 2007
  9. ncbi request reprint Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Obstet Gynaecol Res 32:416-21. 2006
  10. ncbi request reprint Polypoid endocervical adenomyoma: a case report with clinicopathologic analyses
    Shunichiro Ota
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan
    J Obstet Gynaecol Res 33:363-7. 2007

Collaborators

Detail Information

Publications16

  1. doi request reprint Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahi Machi, Kurume, Fukuoka, 830 0011, Japan
    Cancer Chemother Pharmacol 78:785-90. 2016
    ....
  2. doi request reprint Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Asahi machi 67, Kurume, Fukuoka, Japan Electronic address
    Gynecol Oncol 132:703-8. 2014
    ..However, the clinical significance of nuclear YB-1 expression in different settings, the correlation with EGFR, and the prognostic implications of YB-1 expression in cervical cancer remain elusive...
  3. doi request reprint Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia
    Shin Nishio
    Department of Basic Pathology, National Defense Medical College, 3 2 Namiki, Tokorozawa, Saitama 359 8513, Japan
    Pathol Res Pract 205:331-7. 2009
    ..LEGH may be one of the factors related to the development of cervical adenocarcinoma, but adenocarcinoma with LEGH components does not necessarily develop into a highly aggressive "adenoma malignum."..
  4. doi request reprint Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    J Cancer Res Clin Oncol 135:551-7. 2009
    ..Limited information is available regarding the usefulness of third-line chemotherapy for recurrent ovarian, fallopian tube, and primary peritoneal cancer treated with platinum-taxane regimens as first-line therapy...
  5. doi request reprint Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Cancer Lett 264:36-43. 2008
    ..Our results suggest that increased expression of Cap43 is associated with angiogenesis and may be a poor prognostic indicator in women with cervical adenocarcinoma...
  6. ncbi request reprint [A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]
    Shin Nishio
    Division of Medical Oncology, National Cancer Center Hospital
    Gan To Kagaku Ryoho 33:1589-93. 2006
    ..We evaluated the feasibility of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer...
  7. ncbi request reprint Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma
    Shin Nishio
    Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
    Oncol Rep 19:497-503. 2008
    ..03) were independent prognostic factors of survival, respectively. Poor PS and non-chemotherapy groups were found to have poor prognosis in patients with stage IVb CC. Chemotherapy may improve the survival for stage IVb CC...
  8. ncbi request reprint Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka Pretecture, 830 0011, Japan
    Gynecol Oncol 106:342-7. 2007
    ..To evaluate the efficacy and toxicity of combination chemotherapy with intravenous irinotecan and oral etoposide in women with platinum- and taxane-resistant epithelial ovarian cancer...
  9. ncbi request reprint Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Obstet Gynaecol Res 32:416-21. 2006
    ..The aim of this study was to investigate whether fertility preservation influences the clinical outcome in patients with malignant germ cell tumors of the ovary (MGCTO)...
  10. ncbi request reprint Polypoid endocervical adenomyoma: a case report with clinicopathologic analyses
    Shunichiro Ota
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan
    J Obstet Gynaecol Res 33:363-7. 2007
    ..Therefore, the results of these ancillary diagnostic modalities should be interpreted with caution and combined with the gross and light microscopy findings...
  11. pmc Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
    Naotake Tsuda
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Gynecol Oncol 25:229-35. 2014
    ..We assessed whether the electrothermal bipolar vessel sealing device (EBVSD) could decrease the incidence of postoperative lymphocele secondary to pelvic lymphadenectomy...
  12. pmc Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
    Kimio Ushijima
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Gynecol Oncol 24:108-13. 2013
    ..To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical cancer...
  13. ncbi request reprint Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study
    Shin Nishio
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahi Machi, Kurume 830 0011, Japan
    Int J Clin Oncol 8:45-8. 2003
    ..The aim of this study was to evaluate the toxicity and efficacy of weekly paclitaxel in patients with recurrent endometrial cancer...
  14. pmc Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
    Kouichiro Kawano
    Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan
    J Gynecol Oncol 27:e54. 2016
    ..To identify key factors for predicting positive cone margin and appropriate cone length...
  15. doi request reprint Treatment and prognosis of bone metastasis from cervical cancer (KCOG-G1202s)
    Hiroshi Makino
    Department of Obstetrics and Gynecology, Gifu University, Gifu, Japan
    J Obstet Gynaecol Res 42:701-6. 2016
    ..The aim of this study was to clarify the clinical features, treatment modalities and prognosis of bone metastasis in cervical cancer patients in Japan...
  16. doi request reprint Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy
    Seiya Sato
    Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago City Department of Obstetrics and Gynecology, Yamagata University Faculty of Medicine, Yamagata Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi Department of Obstetrics and Gynecology, Jikei University School of Medicine, Minato Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume and Department of Obstetrics and Gynecology, Matsue City Hospital, Matsue, Japan
    Int J Gynecol Cancer 26:561-7. 2016
    ..We conducted this study to evaluate the efficacy and safety of adjuvant chemotherapy using taxane plus carboplatin (CBDCA) for high-risk stage IB-IIB patients with uterine cervical non-squamous cell carcinoma after radical hysterectomy...